Gene · 8239
Papers1,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ubiquitin signatures on aggregating proteins in neurodegeneration. | Essays Biochem | 2025 | 41837791 | PubTator, text mining | PubMed |
| An evaluation of genetic predisposition to congenital anomalies and pediatric cancer supports KAT6B as a novel neuroblastoma susceptibility gene. | Genet Med Open | 2025 | 41542347 | PubTator, text mining | PubMed |
| Persistent Inflammation After Anti-Tubercular Therapy in Tubercular Serpiginous-Like Choroiditis: A Multivariate and Network-Based Risk Analysis. | Transl Vis Sci Technol | 2025 | 41533872 | PubTator, text mining | PubMed |
| Concomitant Mosaic Turner Syndrome and Congenital Adrenal Hyperplasia in 1 of 3 Patients of USP9X Variant-Associated Autism Spectrum Disorder. | Mol Syndromol | 2025 | 41378243 | PubTator, text mining | PubMed |
| Molecular Mechanisms of the Ubiquitin-Specific Proteases (USPs) Family in Biliary Tract Cancer and Targeted Intervention Strategies. | Biomedicines | 2025 | 41301681 | PubTator, text mining | PubMed |
| RHOA lactylation at oncogenic hotspots promotes oncogenic activity and protein stabilization. | Mol Cancer | 2025 | 41291745 | PubTator, text mining | PubMed |
| A rare variant of USP9X associated with female-restricted X-linked syndromic intellectual disability. | Mol Biol Rep | 2025 | 41240171 | PubTator, text mining | PubMed |
| Impact of somatic XIST deletions on ongoing XIST expression and inactive X silencing and heterochromatin. | Hum Mol Genet | 2025 | 41128597 | PubTator, text mining | PubMed |
| NDR1 enhances USP9X-mediated AR deubiquitination and promotes enzalutamide resistance in castration-resistant prostate cancer. | Int J Biol Sci | 2025 | 41079920 | PubTator, text mining | PubMed |
| The deubiquitinase USP9X and E3 ligase WWP1 orchestrate IGF2BP2 ubiquitination homeostasis to drive TNBC progression and cisplatin sensitivity. | Cell Death Dis | 2025 | 41053085 | PubTator, text mining | PubMed |
| USP9X is a mechanosensitive deubiquitinase that controls tumor cell invasiveness and drug response through YAP stabilization. | Cell Rep | 2025 | 41037399 | PubTator, text mining | PubMed |
| USP13 stabilizes NLRP3 to facilitate inflammasome activation by preventing TRIM31-mediated NLRP3 ubiquitination and degradation. | Sci Adv | 2025 | 41004574 | PubTator, text mining | PubMed |
| PRICKLE3-USP9X interaction-mediated DVL2 deubiquitination promotes the progression of non-small cell lung cancer via canonical WNT pathway. | Oncogene | 2025 | 40973792 | PubTator, text mining | PubMed |
| Systemic and Local Lipids in Nonhuman Primates With Drusen and Age-Related Maculopathies. | Invest Ophthalmol Vis Sci | 2025 | 40965406 | PubTator, text mining | PubMed |
| Macrophage-derived KIF13B interacts with USP9X to attenuate abdominal aortic aneurysm development by potentiating TFEB stability. | Theranostics | 2025 | 40963913 | PubTator, text mining | PubMed |
| Role of nitric oxide, prostaglandins, thromboxanes and endothelins in lung cancer: An overview. | World J Clin Cases | 2025 | 40881244 | PubTator, text mining | PubMed |
| DCAF7 recruits USP2 to facilitate hepatocellular carcinoma progression by suppressing clockophagy-induced ferroptosis. | Cell Death Dis | 2025 | 40877242 | PubTator, text mining | PubMed |
| Multi-Wavelength Autofluorescence Characteristics and Association With Inflammation in Acute Posterior Multifocal Placoid Pigment Epitheliopathy. | Invest Ophthalmol Vis Sci | 2025 | 40856650 | PubTator, text mining | PubMed |
| Spautin-1 inhibits the growth of diffuse large B-cell lymphoma by inducing mitochondrial damage-mediated PANoptosis and anti-tumor immunity. | Cancer Immunol Immunother | 2025 | 40853486 | PubTator, text mining | PubMed |
| USP7 promotes temozolomide resistance by stabilizing MGMT in glioblastoma. | Cell Death Dis | 2025 | 40835840 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8239/papers?page=3